This Care of the Aging Patient review reports recommendations for less stringent HbA1c target values for older adults with type 2 diabetes.
This Review summarizes advances in diagnosis and treatment of type 1 and type 2 diabetes between 2005 and 2015.
This randomized trial reports that, among overweight and obese participants with type 2 diabetes, use of daily liraglutide, a glucagon-like peptide 1 analog, resulted in weight loss over 56 weeks compared with placebo.
Kushner and Ryan review current best practices for assessment and lifestyle management of obesity and describe how updated guidelines can be applied to individual patients.
Because 36% of US adults are obese with many unable to lose weight to improve health, Yanovski and Yanovski systematically review medications currently approved for obesity treatment and discuss off-label use of medications studied for obesity and use of obesity medications in clinical practice.